Open AccessThe effect of Dulaglutide on glycemic and weight control in patients with type 2 diabetes
Author(s) -
Alexandru Ioan Ruda,
Dana Mihaela Ciobanu,
Georgeta Inceu,
Adriana Rusu,
Gabriela Román
Publication year - 2022
Publication title -
medicine and pharmacy reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.35
H-Index - 16
eISSN - 2668-0572
pISSN - 2602-0807
DOI - 10.15386/mpr-2425
Subject(s) - dulaglutide , glycemic , type 2 diabetes , medicine , diabetes mellitus , endocrinology , exenatide
The objectives of type 2 diabetes treatment are to achieve adequate long-term glycemic control and to reduce the risk associated with comorbidities and complications. Once-weekly Dulaglutide showed a reduction in cardiovascular risk associated with diabetes in addition to improved glycemic control and bodyweight reduction in several clinical trials. We aimed to investigate the effect of Dulaglutide 1.5 mg on glycemic and weight control in type 2 diabetes patients inadequately controlled by antihyperglycemic treatment in real-world clinical practice.